Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-1212A22.4 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
mRNA | SOX4 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-09 |
mRNA | SEZ6 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | CCDC177 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-08 |
mRNA | TBC1D30 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | ZNF784 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | DOPEY1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | DCHS1 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-08 |
mRNA | RNF165 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-08 |